Rossari Biotech Ltd
NSE: ROSSARI BSE: 543213
₹437.15
+3.85 (0.89%)
Thu, 22 Oct 2026, 07:54 pm
Market Cap (in Cr)2400.5
PE Ratio16.08
Dividend0.12
Process Industries
Chemicals: Specialty
24.5KRossari Biotech Income Statement
| Particulars | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2.35B | 2.92B | 5.16B | 6.00B | 7.09B | 14.83B | 16.56B | 18.31B | 20.80B |
| Gross profit | 385.70M | 643.53M | 1.25B | 1.62B | 1.66B | 2.29B | 2.80B | 3.17B | 3.77B |
| Operating expenses (excl. COGS) | -188.32M | -266.19M | -594.55M | -728.31M | -641.32M | -966.55M | -1.25B | -1.30B | -1.85B |
| Selling/general/admin expenses, total | -188.32M | -266.19M | -594.55M | -727.11M | -641.32M | -957.69M | -1.25B | -1.30B | -1.85B |
| Research & development | -47.10M | -31.39M | -38.62M | -53.53M | -75.01M | -50.27M | -82.55M | -70.17M | -78.27M |
| Selling/general/admin expenses, other | -141.22M | -234.80M | -555.93M | -673.58M | -566.31M | -907.42M | -1.16B | -1.23B | -1.77B |
| Other operating expenses, total | 0 | 0 | 0 | -1.20M | 0 | -8.86M | 0 | 0 | 0 |
| Operating income | 197.38M | 377.34M | 658.21M | 891.82M | 1.02B | 1.32B | 1.55B | 1.87B | 1.91B |
| Non-operating income, total | -10.27M | -2.60M | -24.29M | -11.23M | 48.94M | 26.86M | -117.44M | -91.60M | -71.78M |
| Interest expense, net of interest capitalized | -21.31M | -13.55M | -28.78M | -35.57M | -17.42M | -109.08M | -56.40M | -193.72M | -178.11M |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 10.43M | 10.35M | 4.49M | 24.34M | 36.02M | 77.77M | -75.71M | 98.39M | 105.82M |
| Non-operating interest income | 1.61M | 5.06M | 6.55M | 15.44M | 42.65M | 40.67M | 25.21M | 22.39M | 8.57M |
| Miscellaneous non-operating expense | 8.82M | 5.29M | -2.06M | 8.90M | -6.63M | 37.10M | -100.92M | 75.71M | 96.96M |
| Unusual income/expense | 610.00K | 600.00K | 0 | — | 30.34M | 58.17M | 14.67M | 3.73M | 510.00K |
| Pretax income | 187.11M | 374.74M | 633.92M | 880.59M | 1.06B | 1.35B | 1.43B | 1.77B | 1.84B |
| Taxes | -44.26M | -120.71M | -177.09M | -225.88M | -267.92M | -385.80M | -369.62M | -469.26M | -488.07M |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 | 1.74M | -210.00K | 0 | 0 | 0 |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 142.85M | 254.03M | 456.83M | 652.53M | 802.20M | 976.74M | 1.07B | 1.31B | 1.36B |
| Net income | 142.85M | 254.03M | 456.83M | 652.53M | 802.20M | 976.74M | 1.07B | 1.31B | 1.36B |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 142.85M | 254.03M | 456.83M | 652.53M | 802.20M | 976.74M | 1.07B | 1.31B | 1.36B |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - |
| EBITDA | 240.83M | 429.07M | 780.08M | 1.06B | 1.24B | 1.80B | 2.18B | 2.47B | 2.58B |
| EBIT | 197.38M | 377.34M | 658.21M | 891.82M | 1.02B | 1.32B | 1.55B | 1.87B | 1.91B |
| Total operating expenses | -2.15B | -2.54B | -4.50B | -5.11B | -6.08B | -13.51B | -15.01B | -16.44B | -18.89B |
| Prepaid expenses | 1.04M | 3.06M | 2.79M | 4.15M | 4.93M | 49.49M | 34.56M | 12.48M | 20.11M |
| Deferred income, current | 6.19M | 4.08M | 1.53M | 16.29M | 53.92M | 727.32M | 37.67M | 125.10M | 160.64M |
| Capital and operating lease obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 109.06M | 223.07M |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | 8.35M | 20.52M | 18.12M | 5.40M | 12.88M | 689.49M | 587.20M | 514.72M | 465.67M |
| Deferred income, non-current | — | — | — | — | — | — | — | — | — |
| Minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in accrued expenses | — | — | — | — | — | — | — | — | — |
| Common dividends paid | 0 | -2.65M | -105.92M | -26.48M | -25.38M | -27.53M | -27.53M | -27.58M | -27.65M |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
